Nanoformulation-Based Antiviral Combination Therapy for Treatment of COVID-19

摘要

In December 2019, a novel coronavirus disease (COVID-19) was detected in Wuhan, China, which was accompanied by symptoms of fever, dry cough, weakness of immune system with reduction of the white blood cells. Afterwards, coronavirus has speared and affected many countries in worldwide 1,2.